M13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)

Background: Antipsychotic-induced metabolic dysfunction is problematic in youths with psychosis. We used limited-access data from the NIH-funded Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) study to identify risk factors for neuroleptic-associated metabolic dysfunction. Methods:...

Full description

Saved in:
Bibliographic Details
Published in:Schizophr Bull
Main Authors: Taylor, Jerome, Jakubovski, Ewgeni, Gabriel, Daniel, Bloch, Michael
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475770/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx022.012
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items